Copyright © 2021. Inderes Oyj. All rights reserved.

Faron Pharmaceuticals

Analyytikko

Viimeisin video

Sisäpiirin kaupat

Nettovaikuttavuus

Tiedotteet
7.10.
2021

Faron Pharmaceuticals Ltd

("Faron or the "Company")

Exercise of options

Issue of equity

Company announcement, 7 October 2021 at 02:00 AM (EDT) / 07:00 AM (BST) / 09:00 AM (EEST)

Tiedotteet
5.10.
2021

TR-1: Standard form for notification of major holdings

NOTIFICATION OF
MAJOR HOLDINGS
(to
be sent to the
relevant issuer
and
to the FCA in
Microsoft Word
format
if possible)i

Tiedotteet
1.10.
2021

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Tiedotteet
1.10.
2021

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

Tiedotteet
30.9.
2021

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA, JAPAN, THE REPUBLIC OF SOUTH AFRICA, SINGAPORE, HONG KONG OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.

inderesTV
17.9.
2021

Faron Pharmaceuticalsin toimitusjohtaja Markku Jalkanen kommentoi MATINS-tutkimuksen tuoretta dataa ja löytöjä kansankielisesti Vernerin haastattelussa. Mitkä ovat strategian seuraavia askeleita?

Faronista käydään keskustelua Sijoitusfoorumilla täällä https://keskustelut.inderes.fi/t/faron-pharmaceuticals-breakthrough-immu...

-Videon aiheet-

00:00 Aloitus
00:15 Syöpälääke Bexin MATINS-tutkimuksesta tiedotettiin tänään uutisia, mistä on kyse?

Tiedotteet
17.9.
2021

Faron Pharmaceuticals Ltd.

("Faron")

Faron Announces Presentation of Updated MATINS Data at ESMO Showing Bexmarilimab Delivers Compelling

Antitumour Activity Across Five Different Advanced Solid Tumors

inderesTV
27.8.
2021

Lääkekehitysyhtiö Faronin toimitusjohtaja Markku Jalkanen avaa yhtiötä sijoituskohteena ja vastaa yleisökysymyksiin Verneri Pulkkisen haastattelussa. Kysymykset kellotettuna alla.

Faronista keskustellaan sijoitusfoorumilla täällä https://keskustelut.inderes.fi/t/faron-pharmaceuticals-breakthrough-immu...

-Videon aiheet-

00:00 Aloitus
00:13 Tervetuloa Markku ensimmäiseen inderesTV:n haastikseen, voitko kertoa ensin hieman itsestäsi?

Tiedotteet
26.8.
2021

Faron Pharmaceuticals Oy

("Faron")

Faron Reports Half-Year Financials, January 1 - June 30, 2021

Significant progress made in H1 2021 including acceleration of most advanced pipeline assets - Bexmarilimab and Traumakine[Ò]

August 26, 2021 at 7:00 am BST / 9:00 am EEST

Tiedotteet
25.8.
2021

Faron Pharmaceuticals Oy

("Faron" or the "Company")

Faron Pharmaceuticals Doses First Patient in Phase II/III HIBISCUS Trial of Traumakine for Treatment of Hospitalized COVID-19 Patients

Trial co-funded by US Department of Defense

Company announcement, August 25, 2021 at 9.00 AM (EEST)
Inside information

Faron Pharmaceuticals

ipo